Heng Tai Consumables Group Limited Overview
Heng Tai is a Hong Kong-headquartered micro-cap trading house that imports and distributes packaged foods, beverages, household consumables and fresh produce into mainland China. Its Agri-Products business also includes a small upstream citrus-farming base in Jiangxi Province.
For two decades the model rested on a simple arbitrage: the Chinese consumer's premium for imported, quality-assured goods. That premium has eroded sharply as domestic brands improved quality, cut prices and outspent importers on marketing.
The result is a business in managed contraction:
Revenue: fell from HK$520 million in FY2021 to HK$428 million in FY2025, then collapsed 34% year on year in H1 FY2026.
Losses: more than HK$1 billion cumulatively over five years, dominated by impairments of the Jiangxi farming assets.
Balance sheet: essentially debt-free, with HK$66 million in cash and HK$75 million in bond investments against a market value near HK$60 million.
The Group is now exiting non-core businesses, pivoting towards domestic produce and Chinese-sourced exports, and experimenting with Hong Kong inbound tourism through the V.Profit acquisition.
Company's own description (paraphrased from FY2025 Annual Report and H1 FY2026 Interim)
Management describes the Group as principally engaged in two activities:
-
trading packaged foods, beverages and household consumables (the FMCG Trading Business);
-
trading agri-products and operating an upstream farming business (together, the Agri-Products Business).
Management presents these two businesses as forming two vertically integrated supply chains that deliver perishable and non-perishable consumer products into China.
Until FY2025 there was also a third "Other Business": securities brokerage, margin financing and IPO subscription services through Sino Wealth Securities Limited. Operations of this business ceased during H1 FY2026 [H1 FY2026 Interim Results, 26 Feb 2026].
The Chairman's Statement frames the model as one-stop services covering trading, distribution, marketing and selling of FMCG and agri-products in China, supplemented by upstream cultivation. Management believes this gives the operations a high degree of sustainability [AR FY2025, Chairman's Statement].
Independent characterisation
In economic substance, Heng Tai is a low-margin importer-distributor (gross margin 5–8%) whose key assets are:
-
supplier relationships across Australasia, Europe, the Americas and South-East Asia;
-
distribution rights, carried as intangible assets and repeatedly impaired;
-
a customer book of Chinese wholesalers, on-premise (food-service) operators and e-commerce operators.
Position in the value chain: a mid-stream intermediary. The Group does not manufacture branded goods; it buys finished imported goods and sells them on to domestic resellers. It is therefore squeezed from both sides:
-
Upstream, foreign brand owners and rising sourcing costs (FX, freight, tariffs) push its costs up.
-
Downstream, aggressive domestic brands and cross-border e-commerce compress its selling prices.
The Agri-Products segment combines three activities:
-
imported fresh-fruit trading;
-
domestic fresh-produce trading and processing through the Dongguan processing centre, which serves fast-food chains and school dining halls;
-
an upstream Jiangxi citrus base growing early-crop oranges and ponkans, with a fruit processing centre, a research and test-lab centre, and a stalled agri-tourism park.
The upstream farming unit generates only about HK$14–16 million of revenue a year (FY2022: HK$15.7m; FY2023: HK$14.1m). Yet it has absorbed most of the Group's impairments: about HK$112.8 million in FY2024 and HK$117.1 million in FY2025.
Revenue model
| Revenue type | FY2025 (HKD Mn) | Share | Nature |
|---|---|---|---|
| Sales of consumer goods (FMCG) | 248.7 | 58.1% | Product sales, recognised at a point in time |
| Sales of agri-products (incl. fertiliser trading and minor rental) | 178.2 | 41.6% | Product sales, recognised at a point in time |
| Securities commission and brokerage | 0.03 | 0.0% | Service fees (ceased in H1 FY2026) |
| Margin financing interest | 1.1 | 0.2% | Interest (ceased in H1 FY2026) |
| Total | 428.0 | 100% | Essentially 100% product revenue; no subscription or licensing |
[Source: FY2025 Final Results announcement, Note 3]
Customers and end-markets
Customer types: wholesalers, on-premise customers (restaurants and food service), e-commerce operators and, historically, securities investors [AR FY2025, Key Relationships]. The Dongguan centre supplies established fast-food chain brands and school canteens.
Concentration: no customer exceeded 10% of revenue in FY2022–FY2025. The top five customers took less than 30% of sales in FY2025. The top five suppliers took about 34% of purchases, and the largest single supplier about 8% [AR FY2025, Directors' Report].
End-markets: mainland Chinese consumer food and grocery, accounting for 87% of FY2025 revenue by location of operations, and Hong Kong fresh produce (13%).
Strategy
Stated strategy (themes from AR FY2025 and the H1 FY2026 Interim; paraphrased)
-
Focus on the core. Concentrate on FMCG Trading and Agri-Products Trading, and take a prudent stance on new developments.
-
Rebuild procurement. Reinforce and expand the procurement network to source "suitable and niche" products from both international and domestic suppliers. This acknowledges the improved quality of Chinese products.
-
Export pivot. Explore exports of Chinese products to Asian and European markets, leveraging Chinese price and quality competitiveness.
-
Dongguan expansion. Strengthen the Dongguan processing centre and grow domestic produce supply to food service.
-
Flexible pricing. Use flexible pricing strategies with the aim of maintaining stable gross margins.
-
Upstream caution. Restart Jiangxi new-arable-land, fruit-processing and agri-tourism developments only when the market recovers and a suitable co-investing partner is in place.
-
Cost discipline and streamlining. Continue cost savings and exit unprofitable operations (securities brokerage exited in H1 FY2026).
-
Diversification. Broaden the revenue base, for example through Hong Kong inbound tourism via V.Profit, to offset contraction in the traditional trading businesses.
-
Balance-sheet strength. Maintain a strong and healthy financial position to withstand headwinds.
Initiatives in the last 24 months
| Date | Initiative | Detail / target | Status |
|---|---|---|---|
| May 2024 – Jun 2026 | Fertiliser trading launch | HK$13.9m of 2024 rights proceeds allocated; HK$7.1m used by Dec 2025 | Scaled down in H1 FY2026; deadline extended to 30 Jun 2026 |
| Aug–Dec 2024 | China Healthwise bond restructuring | HK$72.3m rolled into 6% CB (HK$16.8m) and 8% straight bonds (HK$55.5m), maturing 31 Dec 2026 | Fair value HK$75.4m (Dec 2025) |
| FY2025 | Upstream restructuring | One-off restructuring cost of about HK$1.0m; agri-tourism and new arable land deferred | Completed |
| Oct 2025 | Shanghai logistics refurbishment | HK$7.5m from top-up placing, by 31 Oct 2026 | HK$1.0m used by Dec 2025 |
| Oct 2025 | Dongguan equipment and headcount | HK$2.7m, by 31 Oct 2026 | HK$0.8m used by Dec 2025 |
| H1 FY2026 | Exit from securities brokerage | Sino Wealth Securities operations ceased | Completed |
| H1 FY2026 | Imported product pruning | FMCG revenue -41%; imported agri-products scaled down | Ongoing |
| Jan 2026 | Hong Kong tourism entry | V.Profit acquisition (HK$972k) | Completed 30 Jan 2026 |
| Mar 2026 | Management refresh | New ED (Sun Banggui); new CFO and Company Secretary (Kong Qingwen) | Completed |
| Jul 2026 | Audit cost reduction | Switched to Quentin Wong & Co. at HK$0.8m, below a rival HK$1.3m bid (RSM's FY2025 audit fee was HK$2.39m) | Completed; FY2026 results delayed |
ESG commitments
Disclosed commitments are general: resource-saving guidelines (electricity, water), recycling of office supplies, and environmental compliance at food-processing and logistics facilities. A separate ESG report is published on HKEXnews. No quantified targets were identified.
Medium-term financial targets and guidance
None publicly disclosed. Management does not issue numerical guidance. Its qualitative outlook (H1 FY2026) describes the environment as "fraught with uncertainties", with continued cost-saving and streamlining.
Products & Services
The Group does not disclose brand-level revenue, pricing or launch dates. The catalogue below is compiled from management's category disclosures. Named consumer brands are not publicly disclosed in the results documents reviewed.
FMCG Trading Business
| Metric | FY2022 | FY2023 | FY2025 | H1FY2026 |
|---|---|---|---|---|
| Packaged foods share (%) | 78 | 80 | 85 | 84 |
| Beverages share (%) | 15 | 15 | 10 | 9 |
| Household consumables share (%) | 7 | 5 | 5 | 7 |
| Product line | Description | Target customer | Sourcing | Notes |
|---|---|---|---|---|
| Biscuits, candies, chocolate | Imported confectionery and baked snacks | Wholesalers, e-commerce operators | Europe, Australasia, Americas, SE Asia | Core of the packaged-foods category |
| Condiments, margarine | Imported cooking ingredients | Wholesalers, food service | Overseas | — |
| Milk-powder products | Imported dairy powders | Wholesalers, e-commerce | Australasia / Europe (specific origins not disclosed) | Highly competitive category |
| Health food, nourishing products | "Healthy food" and nourishing products | Retail channels | Overseas | — |
| Noodles, snacks, rice | Staples and snacks | Wholesalers | Overseas and, increasingly, domestic | Group now co-operates with domestic manufacturers |
| Exclusively licensed branded products | Products under exclusive distribution licences (carried as intangible "rights for distribution") | Wholesalers | Brand principals (not named) | Distribution rights heavily impaired in FY2022 (HK$39.4m intangible impairment); amortisation reappeared in FY2025 (HK$13.5m) |
| Beverages | Imported drinks | Wholesalers, on-premise | Overseas | Being cut back because of domestic price competition |
| Household consumables | Non-food FMCG | Wholesalers, retail | Overseas | About 5–7% of FMCG revenue |
| Cold-chain products | Chilled and frozen goods (per Morningstar description) | Food service | Overseas | Supported by the Shanghai logistics centre |
Category mix (% of FMCG revenue)
FY2021 packaged-food share was about 70% [FY2022 Results].
Pricing model. Wholesale pricing with credit terms of 30–210 days [FY2025 Results, Note 11]. Management describes a "flexible pricing strategy" and has repeatedly cut selling prices to meet domestic competition.
Agri-Products Business
| Product / service | Description | Target customer | Facility | Status |
|---|---|---|---|---|
| Imported fresh fruit | Fresh produce from Australasia and SE Asia | Wholesalers, retailers in China and Hong Kong | Hong Kong and PRC distribution | Scale significantly reduced in H1 FY2026 |
| Domestic fresh produce | Domestically sourced fruit and vegetables | Food service, school dining halls, fast-food chains | Dongguan processing centre (washing, sorting, grading, packing, storage) | Growing; 35.9% of Agri revenue in H1 FY2026, up from 27.5% |
| Pre-processed / ready-to-cook produce | Cut and processed vegetables and fruit | Established fast-food chain brands, school canteens | Dongguan | Operating since Sep 2022 |
| Self-grown early-crop oranges and ponkans | Citrus from the Jiangxi farming base | Wholesale and retail distribution | Jiangxi orchards plus fruit processing centre | H1 FY2026 revenue -9.5% (price pressure; some orders deferred to Chinese New Year) |
| Fertiliser trading | Ancillary agricultural input trading, funded by the 2024 rights issue | Agricultural buyers | — | Launched FY2025; scaled down in H1 FY2026; HK$6.8m of proceeds unspent (deadline extended to 30 Jun 2026) |
| Agri-tourism (planned) | Pick-your-own farm, restaurant, souvenir shops, hostel within an agricultural science industrial park | Domestic tourists | Jiangxi | Deferred; assets impaired; no travel-agency partner secured |
Other and new businesses
| Business | Description | Status |
|---|---|---|
| Sino Wealth Securities Limited | Securities trading, margin financing, IPO subscription brokerage | Ceased in H1 FY2026 |
| Tourist retailing (jewellery) | Retail to mainland tourists in Hong Kong | Terminated FY2023 |
| Logistics services (third-party) | Warehousing and food-processing lines for third parties | Ceased FY2022 |
| V.Profit International Travel Services Limited | Hong Kong inbound tour-group services for PRC visitors (accommodation coordination, meals, sightseeing, shopping) | Acquired 30 Jan 2026 for HK$972,000 |
Financial Narrative
All figures are in HK$ M for fiscal years ended 30 June, audited, taken from the HKEX final results announcements for FY2022, FY2023 and FY2025 (which include FY2021 and FY2024 comparatives).
Income statement
Notes: - In FY2021–FY2023, non-financial asset impairments (fixed assets, ROU, goodwill, intangibles) were booked within "Other operating expenses". In FY2024–FY2025 they appear as a separate line.
-
EBITDA = loss from operations + depreciation of fixed assets + depreciation of ROU assets + amortisation of intangibles (net of amounts capitalised), per the Note 7 disclosures. It includes impairments.
-
On a pre-impairment basis, FY2025 EBITDA was about -HK$37 million (-159.2 + 117.1 + 4.8), and FY2024 about -HK$35 million.
Per-share data (as reported)
FY2021–FY2023 EPS are on a pre-consolidation basis. A 20-into-1 share consolidation took effect on 28 Dec 2023, and a rights issue followed in May 2024. No dilutive instruments exist; diluted EPS equals basic.
Margin analysis
Revenue CAGR FY2021–FY2025: -4.8% a year (HK$520.3m to HK$428.0m). On a trailing basis to 31 Dec 2025, revenue was about HK$348.0 million (H2 FY2025 HK$189.7m + H1 FY2026 HK$158.3m), down roughly 19% from FY2025.
Balance sheet
Interim balance sheet, 31 Dec 2025 (unaudited):
-
Total assets HK$636.6m; cash HK$65.8m; investments HK$75.5m, of which the China Healthwise bonds are HK$75.4m and are now current.
-
No bank borrowings; lease liabilities HK$5.8m; equity HK$559.8m; net current assets HK$421.5m; current ratio 7.8x [H1 FY2026 Results].
Cash flow
Disclosed proxies:
Other cash-flow facts:
-
Additions to segment non-current assets (a capex proxy): FY2021 HK$52.9m; FY2022 HK$79.3m; FY2023 HK$37.3m; FY2024 HK$36.1m; FY2025 HK$37.4m [segment notes].
-
No dividends have been paid since at least FY2021, and no shares have been repurchased in any year reviewed.
Ratios (computed from audited figures)
Notes: - Invested capital = equity + debt including leases − cash.
- Net debt/EBITDA and interest coverage are not meaningful: EBITDA and EBIT are negative, and the Group is net cash. Finance costs were only HK$0.3–0.6 million a year, almost all lease interest.
Commentary on trends, inflections and drivers
1. Revenue: structural decline, with acceleration in FY2026.
-
Revenue fell 3.7% in FY2022 (COVID lockdowns, Shanghai disruption, beverage-line pruning).
-
It fell 12.1% in FY2023, as post-pandemic pricing normalisation cut volumes and imported produce lost share.
-
It stabilised in FY2024 (+0.3%) and FY2025 (-3.2%), helped by fertiliser trading and price increases on higher-quality produce.
-
H1 FY2026 marks a decisive inflection (-33.6%) because management deliberately exited:
-
unprofitable imported FMCG SKUs;
-
most imported fruit;
-
fertiliser trading;
-
securities brokerage.
-
2. Gross margin: improved, then stalled. Gross margin doubled from 3.4% (FY2021) to 8.3% (FY2024). The main drivers were the removal of distribution-right amortisation from cost of sales after the FY2022 intangible write-down, plus reduced customer discounts. It then slipped to 8.0% (FY2025) and to 5.3% in H1 FY2026, as FMCG prices were cut while sourcing costs rose.
3. Opex: rising, then cut.
-
Selling and distribution expenses jumped 18.9% in FY2025 (fertiliser logistics, freight, distribution-rights amortisation), taking them to 12.1% of revenue.
-
In H1 FY2026, the Group cut selling and distribution costs by 14.6% and administrative costs by 22.2%. This is the first meaningful cost response.
4. Impairment cycle: the dominant driver of losses. Cumulative non-financial impairments and fair-value losses since FY2021 exceed HK$500 million:
-
FY2021: goodwill, ROU, logistics fixed assets and intangibles;
-
FY2022: HK$71.6m on fixed assets, ROU, goodwill, intangibles and other assets;
-
FY2023: HK$26.1m of fair-value losses on investments (Global Mastermind, First Bullion, China Healthwise CB);
-
FY2024: HK$112.8m on Jiangxi assets;
-
FY2025: HK$117.1m on Jiangxi assets.
H1 FY2026 recorded no non-financial impairment. The loss narrowed to HK$33.4m, the first sign that the write-down cycle may have run its course.
5. Balance sheet: equity erosion, but negligible leverage.
-
Equity fell 55%, from HK$1,286m (FY2021) to HK$577m (FY2025).
-
Cash fell 74%, from HK$223m to HK$58m.
-
There is no bank debt.
-
Working capital is the Group's largest asset. Trade receivables over 90 days old (HK$71.5m at FY2025, rising to HK$76.4m at Dec 2025) represent a material collection risk.
6. Liquidity runway. H1 FY2026 cash burn was only HK$4.5 million before financing. Combined with HK$66m of cash and HK$75m of China Healthwise bonds maturing 31 Dec 2026, near-term solvency appears adequate. However, recoverability of the China Healthwise bonds is a key dependency.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products / services |
|---|---|---|
FMCG Trading Business | Sale and trading of fast-moving consumer goods, mostly imported | Packaged foods (biscuits, candies, chocolate, condiments, margarine, milk-powder products, health food, noodles, snacks, rice, nourishing and exclusively licensed branded products); beverages; household consumables |
Agri-Products Business | (i) Agri-Products Trading (imported and domestic fresh produce, fertiliser trading); (ii) Upstream Farming (Jiangxi citrus) | Fresh and processed fruit and vegetables; pre-processed and ready-to-cook produce for food service; early-crop oranges and ponkans; fertiliser |
All other segments (below the reporting threshold) | Securities dealing and margin financing (Sino Wealth Securities; ceased H1 FY2026); tourist retailing (terminated FY2023) | Brokerage commission, IPO subscription, margin interest |
Revenue by Segment
| Segment | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
FMCG Trading revenue (HKD Mn) | 313.0 | 290.5 | 273.7 | 266.5 | 248.7 |
Agri-Products revenue (HKD Mn) | 200.8 | 206.6 | 163.6 | 172.5 | 178.2 |
Logistics Services revenue (HKD Mn) | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 |
All other segments revenue (HKD Mn) | 4.2 | 4.1 | 3.2 | 3.0 | 1.1 |
Total revenue (HKD Mn) | 520.3 | 501.2 | 440.6 | 442.0 | 428.0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
FMCG Trading segment result (HKD Mn) | -45.5 | -72.4 | -3.4 | -14.1 | -25.2 |
Agri-Products segment result (HKD Mn) | -84.4 | -82.1 | -74.6 | -169.1 | -167.5 |
Logistics Services segment result (HKD Mn) | -42.1 | 0.0 | 0.0 | 0.0 | 0.0 |
All other segments result (HKD Mn) | -15.1 | -3.7 | -5.3 | -3.1 | -0.0 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
FMCG segment margin (%) | -14.5 | -24.9 | -1.2 | -5.3 | -10.1 |
Agri-Products segment margin (%) | -42.0 | -39.7 | -45.6 | -98.0 | -94.0 |
FMCG revenue YoY growth (%) | 0.0 | -7.2 | -5.8 | -2.6 | -6.7 |
Agri-Products revenue YoY growth (%) | 0.0 | 2.9 | -20.8 | 5.4 | 3.3 |
FMCG share of total revenue (%) | 60.2 | 58.0 | 62.1 | 60.3 | 58.1 |
Agri-Products share of total revenue (%) | 38.6 | 41.2 | 37.1 | 39.0 | 41.6 |
Segment Assets & Liabilities
| Segment | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
FMCG segment assets (HKD Mn) | 506.3 | 418.1 | 390.8 | 348.2 | 307.1 |
Agri-Products segment assets (HKD Mn) | 538.5 | 546.8 | 495.7 | 350.0 | 202.7 |
Segment Revenue
| Segment | H1 FY2025 revenue (HKD Mn) | H1 FY2026 revenue (HKD Mn) | YoY | H1 FY2025 result (HKD Mn) | H1 FY2026 result (HKD Mn) |
|---|---|---|---|---|---|
FMCG Trading | 140.9 | 82.4 | -41.5% | -7.4 | -11.2 |
Agri-Products | 95.9 | 75.9 | -20.9% | -23.4 | -21.9 |
All other | 1.5 | 0.0 | -100% | +0.8 | -0.5 |
Total | 238.3 | 158.3 | -33.6% | -29.9 | -33.5 |
Income Statement
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 520.3 | 501.2 | 440.6 | 442.0 | 428.0 |
Cost of sales (HKD Mn) | -502.7 | -481.4 | -409.1 | -405.3 | -393.6 |
Gross profit (HKD Mn) | 17.5 | 19.8 | 31.5 | 36.6 | 34.4 |
Fair value change from biological transformation (HKD Mn) | -38.7 | -31.4 | -41.9 | -19.7 | -10.2 |
Other gains and income (HKD Mn) | 20.5 | 10.2 | 10.1 | 12.3 | 10.7 |
Selling and distribution expenses (HKD Mn) | -36.4 | -42.3 | -30.5 | -43.6 | -51.9 |
Administrative expenses (HKD Mn) | -65.6 | -64.4 | -64.3 | -62.4 | -64.7 |
Impairment of financial assets, net (HKD Mn) | -35.3 | -3.3 | -2.8 | -6.3 | -4.8 |
Impairment of non-financial assets (HKD Mn) | 0.0 | 0.0 | 0.0 | -112.8 | -117.1 |
Other operating expenses (HKD Mn) | -111.8 | -97.6 | -27.2 | -0.5 | -1.1 |
Operating income / loss from operations (HKD Mn) | -249.7 | -208.9 | -125.2 | -196.4 | -204.6 |
Finance costs (HKD Mn) | -0.5 | -0.4 | -0.6 | -0.3 | -0.3 |
Pre-tax income (HKD Mn) | -250.1 | -209.4 | -125.7 | -196.7 | -204.9 |
Income tax credit / expense (HKD Mn) | 2.9 | 0.2 | 0.1 | 0.2 | -0.2 |
Net income, total (HKD Mn) | -247.2 | -209.2 | -125.6 | -196.4 | -205.1 |
Net income attributable to owners (HKD Mn) | -247.2 | -216.1 | -125.6 | -196.4 | -205.1 |
Depreciation and amortisation (HKD Mn) | 52.8 | 42.2 | 27.3 | 42.6 | 45.4 |
EBITDA, reported basis (HKD Mn) | -196.9 | -166.7 | -97.9 | -153.8 | -159.2 |
Per-Share Data and Share Count (M)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Basic EPS as reported (HKD) | -0.13 | -0.11 | -0.06 | -1.74 | -1.16 |
Diluted EPS as reported (HKD) | -0.13 | -0.11 | -0.06 | -1.74 | -1.16 |
Dividend per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares (M) | 1,872.7 | 2,000.5 | 2,101.4 | 112.8 | 176.2 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 3.4 | 4.0 | 7.1 | 8.3 | 8.0 |
Operating margin (%) | -48.0 | -41.7 | -28.4 | -44.4 | -47.8 |
EBITDA margin, reported (%) | -37.8 | -33.3 | -22.2 | -34.8 | -37.2 |
Net margin (%) | -47.5 | -41.7 | -28.5 | -44.4 | -47.9 |
Selling and distribution expenses / revenue (%) | 7.0 | 8.4 | 6.9 | 9.9 | 12.1 |
Administrative expenses / revenue (%) | 12.6 | 12.8 | 14.6 | 14.1 | 15.1 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 1,407.5 | 1,224.6 | 1,073.5 | 869.6 | 658.5 |
Bank and cash balances (HKD Mn) | 223.4 | 145.7 | 121.8 | 82.5 | 58.1 |
Pledged bank deposits (HKD Mn) | 17.1 | 16.2 | 12.2 | 2.0 | 0.0 |
Investments, current and non-current (HKD Mn) | 122.6 | 118.1 | 68.4 | 72.7 | 69.1 |
Short-term bank borrowings (HKD Mn) | 15.7 | 12.6 | 10.5 | 0.1 | 0.0 |
Long-term bank borrowings (HKD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Lease liabilities, total (HKD Mn) | 5.5 | 10.7 | 7.3 | 5.9 | 6.5 |
Total debt incl. leases (HKD Mn) | 21.2 | 23.3 | 17.8 | 6.0 | 6.5 |
Net debt incl. leases, negative = net cash (HKD Mn) | -202.2 | -122.4 | -104.0 | -76.5 | -51.6 |
Total equity (HKD Mn) | 1,285.9 | 1,108.3 | 970.1 | 786.9 | 577.0 |
Goodwill and intangibles (HKD Mn) | 43.2 | 0.4 | 0.4 | 3.8 | 7.1 |
Inventories (HKD Mn) | 131.6 | 117.8 | 105.3 | 97.8 | 82.0 |
Trade receivables, net (HKD Mn) | 247.6 | 253.1 | 202.3 | 195.3 | 158.4 |
Trade payables (HKD Mn) | 71.5 | 69.5 | 64.1 | 55.6 | 55.6 |
Working capital, net current assets (HKD Mn) | 672.2 | 672.7 | 506.4 | 448.5 | 355.4 |
Total liabilities (HKD Mn) | 121.7 | 116.2 | 103.4 | 82.7 | 81.6 |
Cash Flow
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Operating loss before working capital changes (HKD Mn) | -14.7 | -12.9 |
Net cash used in operating activities (HKD Mn) | -19.4 | -4.5 |
Purchase of fixed assets, capex (HKD Mn) | -0.3 | -1.0 |
Free cash flow, OCF minus capex (HKD Mn) | -19.6 | -5.5 |
Net proceeds from share placings (HKD Mn) | 4.6 | 14.2 |
Dividends paid (HKD Mn) | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on average equity (%) | -19.2 | -17.5 | -12.1 | -22.4 | -30.1 |
ROA on average assets (%) | -17.6 | -15.9 | -10.9 | -20.2 | -26.8 |
ROIC, operating loss / average invested capital (%) | -23.0 | -20.2 | -13.5 | -24.9 | -33.1 |
Current ratio (x) | 7.3 | 8.1 | 6.9 | 7.8 | 6.4 |
Debt / equity incl. leases (%) | 1.6 | 2.1 | 1.8 | 0.8 | 1.1 |
Asset turnover (x) | 0.37 | 0.38 | 0.38 | 0.45 | 0.56 |
DSO, trading receivables (days) | 153 | 164 | 151 | 147 | 135 |
DIO (days) | 96 | 89 | 94 | 88 | 76 |
DPO, trading payables (days) | 48 | 50 | 51 | 50 | 51 |
Cash conversion cycle (days) | 201 | 203 | 194 | 185 | 160 |
Revenue by Region
| Region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC excluding Hong Kong revenue (HKD Mn) | 470.7 | 449.8 | 393.3 | 388.1 | 372.7 |
Hong Kong revenue (HKD Mn) | 49.6 | 51.5 | 47.3 | 53.8 | 55.3 |
Other regions revenue (HKD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Growth metric (%)
| Growth metric (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
PRC revenue YoY growth (%) | -4.4 | -12.6 | -1.3 | -4.0 |
Hong Kong revenue YoY growth (%) | 3.8 | -8.1 | 13.9 | 2.7 |
PRC share of total revenue (%) | 89.7 | 89.3 | 87.8 | 87.1 |
Revenue by Region by Segment × Region
| Segment × region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Consumer goods in PRC (HKD Mn) | 313.0 | 287.2 | 273.7 | 266.5 | 248.7 |
Consumer goods in Hong Kong (HKD Mn) | 0.0 | 3.3 | 0.0 | 0.0 | 0.0 |
Agri-products in PRC (HKD Mn) | 155.4 | 162.6 | 119.6 | 121.6 | 124.0 |
Agri-products in Hong Kong (HKD Mn) | 45.4 | 44.0 | 44.0 | 50.9 | 54.2 |
Securities dealing in Hong Kong (HKD Mn) | 1.6 | 1.2 | 0.9 | 0.6 | 0.0 |
Data Point Details
| Data point | Value | Source |
|---|---|---|
Share price, 24 Apr 2026 | HK$0.285 | ETNet |
Share price, 4 May 2026 | HK$0.300 | Investing.com |
Price on 8 Oct 2025 (placing reference) | HK$0.580 | H1 FY2026 Results |
Top-up placing price, Oct 2025 | HK$0.476 | H1 FY2026 Results |
Price on 19 Jul 2024 (placing reference) | HK$0.241 | FY2025 Results |
Rights issue price, May 2024 | HK$0.350 | HKEX |
Market capitalisation (May 2026) | About HK$60–63m | Computed; Investing.com shows HK$60.67m |
P/E | Not meaningful (loss-making) | — |
P/B | About 0.11x (HK$60m / HK$559.8m equity at Dec 2025) | Computed |
EV/Sales (TTM) | About 0.0x. EV ≈ market cap HK$60m + leases HK$5.8m − cash HK$65.8m ≈ HK$0m, before netting HK$75.5m of investments | Computed |
EV/EBITDA | Not meaningful (negative EBITDA) | — |
P/S (TTM revenue HK$348.0m) | About 0.17x | Computed |
Balance Sheet and Share Count (M)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Share capital, nominal (HKD Mn) | 187.3 | 210.1 | 210.1 | 1.6 | 1.8 |
Weighted average shares (M) | 1,872.7 | 2,000.5 | 2,101.4 | 112.8 | 176.2 |
Dividends per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Equity raised, net (HKD Mn) | 0.0 | 23.8 | 0.0 | 17.4 | 4.6 |
Analyst Conclusions
Management guidance
Management gives no numerical guidance. Its qualitative outlook (H1 FY2026, 26 Feb 2026) expects continued uncertainty from China's property crisis and US trade policy. It commits to:
-
cost-saving initiatives;
-
streamlining unprofitable operations;
-
diversification, including V.Profit;
-
maintaining a strong financial position.
Consensus growth expectations
None available; there is no analyst coverage. The run-rate implied by H1 FY2026 points to FY2026 revenue of roughly HK$300–330m, down about 25% year on year. This is an analyst extrapolation, not company guidance. The audited FY2026 figures are delayed.
Bull case
-
Deep value with downside protection. At about HK$60m market cap, the stock trades below cash plus bond investments (about HK$141m at Dec 2025) and at 0.11x book. There is no debt.
-
The impairment cycle may be over. Jiangxi assets have been written down by more than HK$230m and now carry a much lower base. H1 FY2026 showed no impairment and a narrower loss (HK$33.4m vs HK$38.2m). If FY2026 is clean, reported losses could fall by more than 50% year on year.
-
Real cost restructuring. Opex was cut by more than 18% in H1 FY2026 and operating cash burn fell to HK$4.5m per half. A leaner domestic-produce and Dongguan-centred model could approach cash break-even.
Bear case
-
Structural obsolescence. The imported-goods premium in China is collapsing. FMCG revenue fell 41% in H1 FY2026 and gross margin compressed to 5.3%. No credible replacement engine exists, and V.Profit is immaterial at a HK$1m cost.
-
Asset-quality and governance red flags. The record includes:
-
an auditor resignation after year-end;
-
late FY2026 results and possible suspension;
-
a finance-team overhaul;
-
an ED bankruptcy;
-
large exposure to a single small-cap issuer (China Healthwise);
-
receivables over 90 days equal to 60% of the book. Book value may be overstated.
-
-
Value trap through dilution. The Group has raised equity three times in 18 months (rights issue, placing, top-up) at deep discounts. Cumulative losses have halved equity since FY2021. Without a corporate action, the discount to book may persist indefinitely.
Key catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | Why it matters |
|---|---|---|
| Publication of audited FY2026 results and any auditor modification | Before end-Nov 2026 (company target) | Determines trading resumption; tests book value, impairments and going concern |
| Trading suspension and resumption status | Oct–Dec 2026 | Liquidity and delisting risk |
| China Healthwise bond repayment or conversion (HK$72.3m) | 31 Dec 2026 | About 13% of equity; core liquidity |
| H1 FY2027 interim results | Feb 2027 | Evidence of stabilisation after the pruning |
| V.Profit contribution and segment disclosure | FY2026/FY2027 reports | Viability of tourism diversification |
| Dongguan and Shanghai capex completion | By 31 Oct 2026 | Execution of the domestic-produce strategy |
| Any corporate action (privatisation, asset sale, capital return) | Unknown | Potential crystallisation of discount to NAV |
| Board composition and INED compliance after March 2026 | Ongoing | Governance credibility; Listing Rule 3.10 compliance |
Analyst verdict
Heng Tai is a case study in the erosion of a business model. For more than two decades its proposition was to bring quality-assured foreign food into China. That proposition has been overtaken by domestic brands that now match imported quality at lower prices, backed by marketing budgets Heng Tai cannot match.
Management's response has mixed sensible retrenchment with costly diversification. The exits from logistics, tourist retail and securities were rational. The ventures into digital assets, a Jiangxi agri-tourism park and fertiliser trading have destroyed value, and over HK$500 million of impairments and fair-value losses have been booked since FY2021. Equity has more than halved in four years.
The reason the stock still demands attention is its balance sheet. With no debt, about HK$66 million in cash and HK$75 million in bonds against a market value near HK$60 million, investors are paying roughly nothing for the operating business and a heavily written-down asset base. H1 FY2026 offers tentative evidence of discipline: no impairments, deep opex cuts and minimal cash burn.
That case is now overshadowed by process risk. The auditor's resignation after the fiscal year-end, a hurried low-fee replacement and the failure to publish FY2026 results on time are red flags. Investors should not assume book value is reliable until audited accounts are in hand. The 31 December 2026 maturity of the China Healthwise bonds is a second binary test of asset quality.
Verdict: Speculative / Avoid pending audited FY2026 results. The NAV discount is real but cannot be underwritten until three things happen:
-
audited FY2026 accounts are published with a clean opinion;
-
trading resumes;
-
the China Healthwise bonds are repaid.
For special-situations investors, a clean audit combined with bond repayment would be the trigger to reassess. Without a corporate action to unlock value, continued cash burn and dilution are the likelier path.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Board tenure | Age (AR FY2025) | Background |
|---|---|---|---|---|
Lam Kwok Hing | Chairman, Managing Director, Executive Director and CEO; member of Remuneration and Nomination Committees | ED since Apr 2001; CEO since Mar 2012 | 69 | Co-founder (1994); more than 30 years in consumer products; led the Group from packaged-food trading house to integrated distributor; director of Best Global Asia Limited. Education not disclosed. |
Lee Choi Lin Joecy | Executive Director | Since Apr 2001 | 65 | Co-founder; spouse of Mr Lam; more than 20 years in FMCG marketing and distribution; responsible for general administration |
Chan Cheuk Yu Stephen | Executive Director | Since Feb 2017 | 48 | BSc (first-class honours) Financial Economics, Coventry University; MSc Finance, Imperial College London; former executive director of institutional sales at a brokerage; more than 15 years in investment banking and securities; owns Glazy Target Limited |
Sun Banggui (formerly Sun Bangshi) | Executive Director | Since 11 Mar 2026 | — | — |
Mak Yun Chu | INED; Chair of Audit, Remuneration and Nomination Committees | Since Apr 2004 (more than 9 years) | 67 | FCCA, HKICPA CPA; more than 20 years in accounting; INED of Kingkey Financial International (1468) since Mar 2016 |
Poon Yiu Cheung Newman | INED; member of all three committees | Since Nov 2003 (more than 9 years) | 71 | BA in Accounting and Economics, University of Alberta; former senior insurance executive and hotel accountant |
Hung Hing Man | INED (status after Mar 2026 unclear) | Since Feb 2017 | 55 | MBA, University of Western Sydney; FCCA, HKICPA, TIHK; proprietor of a CPA firm. |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Role | Notes |
|---|---|---|
Kong Qingwen | CFO, Company Secretary, Authorised Representative (from 11 Mar 2026) | Replaced Huang Zhaokang (CFO) and Zhu Yijie (Company Secretary) |
Wong Siu Hong (Huang Zhaokang) | CFO until 11 Mar 2026 | Joined Mar 2003; HKICPA and CPA Australia; age 57 |
Chu Yi Chit (Zhu Yijie) | Company Secretary and Chief Investment and Corporate Relations Officer (Jan 2025 – Mar 2026) | Joined May 2012; MSc LSE; CFA charterholder, HKICPA |
Hung Sau Yung Rebecca | General Manager, group administration and accounting | Joined Mar 1998; former ED (2012–2018) |
Directors' Remuneration
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Directors' emoluments, aggregate (HKD Mn) | 2.70 | 2.69 |
Major Shareholders
| Holder | Shares | % of issued (31 Dec 2025) | Notes |
|---|---|---|---|
Lam Kwok Hing (beneficial; Best Global Asia Ltd previously held 20.6m) | 30,606,157 | 14.63% | Ms Lee deemed interested (spousal) |
Chow Yin Man | 24,898,774 | 11.90% | Down from 25,753,774 (14.42%) at 30 Jun 2025 |
Glazy Target Limited (Chan Cheuk Yu Stephen) | 15,053,003 | 7.20% | — |
Disclosed insiders and substantial holders | 70,557,934 | 33.7% | — |
Public float | about 138.7m | about 66.3% | Sufficient public float confirmed (≥25%) |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning versus Heng Tai |
|---|---|---|---|
FMCG import distribution (China) | Domestic Chinese FMCG brands (category leaders in snacks, dairy and beverages) | Brand owners | Management's primary competitive threat: price-aggressive, ad-heavy, rising quality |
FMCG import distribution | Cross-border e-commerce platforms (Tmall Global, JD Worldwide, etc.) | Platforms | Disintermediate traditional importers; cited in the risk factors |
FMCG distribution (HK/China) | Dah Chong Hong (DCH; CITIC group) | Diversified distributor | Far larger scale and logistics network; its own mainland food segment has struggled historically |
FMCG distribution | COFCO-affiliated import platforms | State-owned trading | Scale and procurement advantages |
Fresh fruit (China) | Shenzhen Pagoda Industrial (2411.HK) | Fruit retail and franchise | FY2025 revenue RMB8.17bn (-20.4%), gross margin 7.3%; loss attributable RMB317m |
Fresh fruit import (China) | Joy Wing Mau (private) | Fruit importer and distributor | Major national importer; financials not public |
Fresh fruit import | Goodfarmer (Jiayuan; private) | Fruit importer, grower and distributor | Integrated importer with upstream assets |
Fresh fruit retail | Hongjiu Fruit, Xianfeng Fruit | Fruit chains | Cited alongside Pagoda as leading players |
Citrus cultivation (Jiangxi/Gannan) | Local Gannan navel-orange co-operatives and growers | Growers | Domestic oversupply pressured H1 FY2026 citrus prices |
Food-service produce processing | Regional central-kitchen and produce processors | Processors | Fragmented; Dongguan centre competes locally |
HK inbound tourism (new) | Established Hong Kong inbound tour operators | Travel agencies | V.Profit is a sub-scale entrant (HK$1m acquisition) |
Securities brokerage (exited) | Hong Kong small-cap brokers | Brokers | Exited H1 FY2026 |
Peer Comparison FY2025
| Metric | Heng Tai (FY2025, Jun) | Shenzhen Pagoda (FY2025, Dec) |
|---|---|---|
Revenue | HK$428.0m | RMB8,174m |
Revenue growth | -3.2% | -20.4% |
Gross margin | 8.0% | 7.3% |
Net result | -HK$205.1m (net margin -47.9%) | Loss attributable RMB317m |
R&D intensity | Not disclosed (below 1% estimated from capex allocations) | — |
Recent Developments
This is a micro-cap with limited disclosure; all identifiable announcements are listed.*



